6-methylthiopurine has been researched along with Abnormalities, Drug-Induced in 1 studies
6-methylthiopurine : A thiopurine that is 9H-purine substituted by a methylsulfanyl group at position 6.
Abnormalities, Drug-Induced: Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
Excerpt | Relevance | Reference |
---|---|---|
"Pregnancy has a major effect on maternal thiopurine metabolism." | 2.79 | Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease. ( de Boer, NK; de Jong, DJ; Dijkstra, G; Hommes, DW; Jharap, B; Mulder, CJ; Oldenburg, B; Stokkers, P; van Bodegraven, AA; van der Woude, CJ; van Elburg, RM, 2014) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jharap, B | 1 |
de Boer, NK | 1 |
Stokkers, P | 1 |
Hommes, DW | 1 |
Oldenburg, B | 1 |
Dijkstra, G | 1 |
van der Woude, CJ | 1 |
de Jong, DJ | 1 |
Mulder, CJ | 1 |
van Elburg, RM | 1 |
van Bodegraven, AA | 1 |
1 trial available for 6-methylthiopurine and Abnormalities, Drug-Induced
Article | Year |
---|---|
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Anemia, Neonatal; Azathioprine; Biomarkers; Female; | 2014 |